Evidence map›Paper›PMID 37111982›Full record

ReviewPolymers2023

Recent Advances in Nanoparticle Development for Drug Delivery: A Comprehensive Review of Polycaprolactone-Based Multi-Arm Architectures.

Ridouan El Yousfi, Mohamed Brahmi, Mohammed Dalli, Nafea Achalhi, Omar Azougagh, Abdesselam Tahani, Rachid Touzani, Abderrahmane El Idrissi

Abstract readReview
In one paragraph

Review in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ridouan El YousfiLaboratory Applied Chemistry and Environmental (LCAE-URAC18), Faculty of Sciences of Oujda, University Mohamed Premier, Oujda 60000, Morocco.ORCID 0000-0002-9375-6880
Mohamed BrahmiPhysical Chemistry of Natural Substances and Process Team, Laboratory of Applied Chemistry and Environment (LCAE-CPSUNAP), Department of Chemistry, Faculty of Sciences, University Mohamed Premier, Oujda 60000, Morocco.ORCID 0000-0002-0230-4492
Mohammed DalliLaboratory of Microbiology, Faculty of Medicine and Pharmacy, University Mohamed Premier, Oujda 60000, Morocco.ORCID 0000-0002-0722-7414
Nafea AchalhiLaboratory Applied Chemistry and Environmental (LCAE-URAC18), Faculty of Sciences of Oujda, University Mohamed Premier, Oujda 60000, Morocco.
Omar AzougaghLaboratory of Molecular Chemistry, Materials and Environment (LMCME), Department of Chemistry, Faculty Multidisciplinary Nador, University Mohamed Premier, P. B. 300, Nador 62700, Morocco.ORCID 0000-0002-8692-0304
Abdesselam TahaniPhysical Chemistry of Natural Substances and Process Team, Laboratory of Applied Chemistry and Environment (LCAE-CPSUNAP), Department of Chemistry, Faculty of Sciences, University Mohamed Premier, Oujda 60000, Morocco.
Rachid TouzaniLaboratory Applied Chemistry and Environmental (LCAE-URAC18), Faculty of Sciences of Oujda, University Mohamed Premier, Oujda 60000, Morocco.ORCID 0000-0001-7333-697X
Abderrahmane El IdrissiLaboratory Applied Chemistry and Environmental (LCAE-URAC18), Faculty of Sciences of Oujda, University Mohamed Premier, Oujda 60000, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Controlled drug delivery is a crucial area of study for improving the targeted availability of drugs; several polymer systems have been applied for the formulation of drug delivery vehicles, including linear amphiphilic block copolymers, but with some limitations manifested in their ability to form only nanoaggregates such as polymersomes or vesicles within a narrow range of hydrophobic/hydrophilic balance, which can be problematic. For this, multi-arm architecture has emerged as an efficient alternative that overcame these challenges, with many interesting advantages such as reducing critical micellar concentrations, producing smaller particles, allowing for various functional compositions, and ensuring prolonged and continuous drug release. This review focuses on examining the key variables that influence the customization of multi-arm architecture assemblies based on polycaprolactone and their impact on drug loading and delivery. Specifically, this study focuses on the investigation of the structure-property relationships in these formulations, including the thermal properties presented by this architecture. Furthermore, this work will emphasize the importance of the type of architecture, chain topology, self-assembly parameters, and comparison between multi-arm structures and linear counterparts in relation to their impact on their performance as nanocarriers. By understanding these relationships, more effective multi-arm polymers can be designed with appropriate characteristics for their intended applications.

Indexed as

drug deliverymulti-arm polymerspolycaprolactoneself-assemblyvesicles

Identifiers

PMID37111982
PMCPMC10142392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.